Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membranes to Human Fibroblast-Derived Dermal Substitute in the Treatment of Chronic Diabetic Foot Ulcers (DFUs) in a Multicenter Ra

World News: . []

COLUMBIA Md Aug 27 2018 GLOBE NEWSWIRE -- LINK  OSIR a regenerative medicine company LINK  on developing and marketing products for wound care orthopedics and LINK  medicine announced today that a new peer-reviewed manuscript e ntitled...

More news and information about Osiris Therapeutics, Inc.

Published By:

Globe Newswire: 21:30 GMT Monday 27th August 2018

Published: .

Search for other references to "osiris" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us